Awards

Niccolò Terrando, BSc, DIC, PhD
Neurovascular Dysfunction in Delirium Superimposed on Dementia
Award Date: 5/18/2021
Funding Agency: National Institutes of Health
Grant Amount: $526,781

Satya Achanta, DVM, PhD, DABT
Specialized Pro-Resolving Mediators as Potential Medical Countermeasures in a Pig Model of Chlorine Gas-Induced Acute Lung Injury
Award Date: 5/6/2021
Funding Agency: National Institutes of Health
Grant Amount: $241,500

Richard E. Moon, MD, CM, MSc, FRCP, FACP, FCCP
Integrated Diaphragmatic Function, Chemosensitivity, Erythrocyte Gas Transport and Endurance in Exercising Divers
Award Date: 4/27/2021
Funding Agency: Office of Naval Research
Grant Amount: $1,209,589

Miles Berger, MD, PhD
Neuro-Inflammation in Postoperative Cognitive Dysfunction: CSF and fMRI Studies
Award Date: 4/22/2021
Funding Agency: National Institutes of Health
Grant Amount: $235,775

Jamie R. Privratsky, MD, PhD
The Role of the IL-1 Receptor in the AKI to CKD Transition
Award Date: 4/15/2021
Funding Agency: National Institutes of Health
Grant Amount: $187,854

Richard E. Moon, MD, CM, MSc, FRCP, FACP, FCCP
Perfluoromethane to Reduce Decompression Sickness
Award Date: 3/25/2021
Funding Agency: Naval Sea Systems Command
Grant Amount: $361,919

Ashraf S. Habib, MBBCh, MSc, MHSc, FRCA
Covance HSK3486-304
Award Date: 2/26/2021
Funding Agency: Haisco-USA Pharmaceuticals, Inc.

William Maixner, DDS, PhD
Role of Preoperative Baroreflex Sensitivity on Postoperative and Persistent Pain after Thoracic Surgery
Award Date: 2/3/2021
Funding Agency: National Institutes of Health
Grant Amount: $201,250

Sven-Eric Jordt, PhD
Project 1: Effects of Flavors on Nicotine Choice and Central Reward Me
Award Date: 1/28/2021
Funding Agency: Yale University

Ashraf S. Habib, MBBCh, MSc, MHSc, FRCA
HERON HTX-011
Award Date: 1/11/2021
Funding Agency: Heron Therapeutics, Inc.

Noa Segall, PhD
Designing Informative and Trustworthy Augmented Intelligence Health Risk Prediction and Surveillance
Award Date: 1/5/2021
Funding Agency: Idaho State University

Madan M. Kwatra, PhD
Prurigo Nodularis: Disease Burden and Rationale for Novel Therapeutics
Award Date: 1/16/2020
Funding Agency: Galderma

Vijay Krishnamoorthy, MD, PhD
Mechanisms and Clinical Impact of Myocardial Injury Following Traumatic Brain Injury
Award Date: 9/6/2019
Award Type: K23
Funding Agency: NIH and the National Institute of Neurological Disorders and Stroke (NINDS)
Grant Amount: $944,405

David S. Warner, MD
Pharmacologic Suppression of Reperfusion Injury Following Endovascular Thrombectomy In Stroke
Award Date: 9/2/2019
Funding Agency: NIH and the National Institute of Neurological Disorders and Stroke (NINDS)
Grant Amount: $475,175

Wei Yang, PhD
Exploring Cell-Based Therapy in Ischemic Stroke
Award Date: 8/8/2019
Funding Agency: Duke University and Duke-NUS Medical School

Sven-Eric Jordt, PhD and Satya Achanta, DVM, PhD
Advanced TRPA1 Inhibitor for the Treatment of Chlorine Inhalation Injury
Award Date: 8/26/2019
Award Type: U01
Funding Agency: NIH and the National Institute of Environmental Health Services (NIEHS)
Grant Amount: $2,305,444

Niccolò Terrando, BSc (hons), DIC, PhD
Bioelectronic Regulation of CNS Lymphatic Drainage in Delirium and AD
Award Date: 8/23/2019
Funding Agency: Alzheimer’s Association
Grant Amount: $150,000

John Whittle, MBBS, MD, FHEA, FRCA, FFICM
Preoperative Exercise to Improve Vagal Tone (PREVENT) Study
Award Date: 8/6/2019
Funding Agency: International Anesthesia Research Society

Niccolò Terrando, BSc (hons), DIC, PhD and Paul E. Wischmeyer, MD, EDIC
Targeting Microbially-Derived Juvenile Protective Factors to Resolve Neuroinflammation and Delirium
Award Date: 7/13/2019
Award Type: R03
Funding Agency: National Institutes of Health
Grant Amount: $322,000

David B. MacLeod, MB BS, FRCA, Dip IMC
Exparel Hip Fracture
Award Date: 7/18/2019
Funding Agency: Pacira Pharmaceuticals
Grant Amount: $412,108

Madan M. Kwatra, PhD
Heterogeneity of EGFRvIII-Positive Glioblastoma and Their Sensitivity to AZD9291 (Osimertinib)
Award Date: 7/15/2019
Funding Agency: Musella Foundation For Brain Tumor Research & Information, Inc

Raquel R. Bartz, MD, MMCi
Implementation of Real Time Application for Portable Interactive Devices (RAPID) BLOCKCHAIN
Award Date: 7/9/2019
Funding Agency: University of Southern California

Jorn A. Karhausen, MD
Enhanced Neutrophil SUMOylation as a Key to Anti-Inflammatory Effects of Hypothermia
Award Date: 6/7/2019
Award Type: 2019 Innovative Project Award
Funding Agency: American Heart Association

Richard E. Moon, MD, CM, MSc, FRCP(C), FACP, FCCP
STEM Outreach Program: Design of a Passive Water Sampler to Test Dive Sites Suspected to be Contaminated
Award Date: 6/6/2019
Funding Agency: Office of Naval Research
Grant Amount: $85,362

Ulrike Hoffmann, MD, PhD
High Resolution Awake Cortical Recordings to Analyze the Role of Spreading Depolarizations During Dynamic Stroke Evolution
Award Date: 4/5/2019
Funding Agency: National Institutes of Health
Grant Amount: $426,854

Richard E. Moon, MD, CM, MSc, FRCP(C), FACP, FCCP
Southampton/Extreme Everest Education Agreement
Award Date: 3/27/2019
Funding Agency: University of Southampton

Michael L. James, MD, FAHA, FNCS
CN105 to Improve Long-Term Recovery in Models of Intracerebral Hemorrhage
Award Date: 3/27/2019
Funding Agency: AegisCN, LLC

Ashraf S. Habib, MBBCh, MSc, MHSc, FRCA
402-C-414 Exparel versus SOC in CS
Award Date: 3/26/2019
Funding Agency: Pacira Pharmaceuticals

Raquel R. Bartz, MD, MMCi
Vitamin C, Thiamine And Steroids in Sepsis: The VICTAS Study
Award Date: 3/26/2019
Funding Agency: Johns Hopkins University

Jamie R. Privratsky, MD, PhD
The Role of the IL-1 Receptor in the AKI to CKD Transition
Award Date: 3/19/2019
Award Type: K08
Funding Agency: National Institutes of Health’s National Institute of General Medical Sciences
Grant Amount: $939,324

Richard E. Moon, MD, CM, MSc, FRCP(C), FACP, FCCP
Sildenafil for Prevention of Immersion Pulmonary Edema
Award Date: 1/28/2019
Funding Agency: Naval Sea Systems Command
Grant Amount: $299,115

Mihai V. Podgoreanu, MD, FASE
Allergan Botox II
Award Date: 1/7/2019
Funding Agency: Allergan, Inc.